Hisato Kawakami, Satoshi Yuki, Ryohei Kawabata, Sho Sato, Akira Ooki, Kunihiro Tsuji, Takeshi Kawakami, Toshifumi Yamaguchi, Hisanobu Oda, Taichi Yoshida, Kazuaki Harada, Yohei Kubota, Kyongsun Pak, Yoshihiro Kakeji, Masanori Terashima, Eishi Baba, Kei Muro, Yu Sunakawa, Masashi Fujii, Wataru Ichikawa. "Safety run-in results from C-SOLVE (JACCRO GC-12): A randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in patients with HER2-negative, CLDN18.2-positive unresectable advanced gastric or GEJ cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.352